AUTOLOGOUS LEUKEMIA-SPECIFIC T-CELL-MEDIATED LYMPHOCYTOTOXICITY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

被引:64
作者
LEE, SK [1 ]
OLIVER, RTD [1 ]
机构
[1] ST BARTHOLOMEWS HOSP,DEPT MED ONCOL,IMPERIAL CANC RES FUND,LONDON EC1,ENGLAND
关键词
D O I
10.1084/jem.147.3.912
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:912 / 922
页数:11
相关论文
共 31 条
[1]  
ALLISON AC, 1977, CANCER IMMUNOL IMMUN, V2, P151
[2]  
BALDWIN RW, 1977, 3RD P INT C IMM
[3]  
BROCHIER J, 1976, IMMUNOLOGY, V31, P749
[4]   MANAGEMENT OF ADULT ACUTE MYELOGENOUS LEUKEMIA [J].
CROWTHER, D ;
POWLES, RL ;
BATEMAN, CJT ;
BEARD, MEJ ;
GAUCI, CL ;
WRIGLEY, PFM ;
MALPAS, JS ;
FAIRLEY, GH ;
SCOTT, RB .
BMJ-BRITISH MEDICAL JOURNAL, 1973, 1 (5846) :131-137
[5]   FACTORS INFLUENCING PROGNOSIS IN ADULTS WITH ACUTE MYELOGENOUS LEUKEMIA [J].
CROWTHER, D ;
BEARD, MEJ ;
BATEMAN, CJT ;
SEWELL, RL .
BRITISH JOURNAL OF CANCER, 1975, 32 (04) :456-464
[7]  
EIJSVOOGEL VP, 1973, TRANSPL P, V5, P1675
[8]  
EIJSVOOGEL VP, 1973, TRANSPL P, V5, P1301
[9]  
FELLOUS M, 1975, HISTOCOMPATIBILITY T, P708
[10]   FURTHER EVIDENCE FOR DEREPRESSION OF H-2 AND IA-LIKE SPECIFICITIES OF FOREIGN HAPLOTYPES IN MOUSE TUMOR-CELL LINES [J].
GARRIDO, F ;
FESTENSTEIN, H ;
SCHIRRMACHER, V .
NATURE, 1976, 261 (5562) :705-707